Cashing in on cancer's eye-catching currency: The coming IVF storm

Maybe you've read the alarming medical headline recently, stating that children born by In Vitro fertilization (IVF) are at an increased risk of developing cancer.

Maybe you've read that these kids have a 42% higher chance of developing cancer than their non-IVF peers.

Maybe you've read that kids born by IVF have a shocking 87% chance of receiving a cancer diagnosis before the age of 3 than their non-IVF peers.

If you haven't read it yet, you will.

Statistically, or mathematically, there's nothing refutable about these figures. They're just enormously misleading.

UNDERNEATH THE HEADLINE

The truth is this: A team of Swedish researchers did a retrospective analysis of the medical records of 26,692 kids born by IVF between 1982 and 2005. Using pre-established epidemiological figures, they expected to find 38 cancer diagnoses.

Instead, they found 53. 15 more than they expected.

Unless you read the actual paper published in the journal Pediatrics, you won't read that three previous, peer-reviewed studies from Sweden failed to find any such increased risk.

You won't read that the authors themselves said they failed to determine whether IVF had any actual role in causing cancer.

Finally, you won't read that members of the same research group behind this study were responsible for one of those previous studies.

This last point made me wonder if the authors had some agenda; maybe they're anti-IVF, some people are because of the procedure's requisite destruction of embryos. But such an agenda would be near impossible to prove. The study's funding, always a great place to look, was provided by a grant from the Evy and Gunnar Sandberg Foundation, which appears to fund many pediatric studies in Sweden, but which is otherwise rather opaque.

SO …

Bottom line, what is the point of this research?

I have no clue. But here's what I do know about it:

  • -- It contributes to the academic prestige of the authors
  • -- It generates media headlines, contributing to the greater prestige of everyone and everything associated with it, from the journal itself to the funding foundation
  • --It does not offer clinicians or would-be IVF parents anything constructive; at best it will only lead to unnecessary confusion thanks to uninformed comments ("You're doing IVF huh? I hear that causes cancer!")
  • --It represents one more example of the severe shortcomings of the media when it comes to medical reporting, specifically as it regards cancer.

In medical journalism, headlines-- however accurate-- bear the real currency of the content, and will therefore always trump science. All you can do to fight this is to read beyond the headlines, or don't read them at all.

By Ross Bonander

Citation

Bengt Källén, Orvar Finnström, Anna Lindam, Emma Nilsson, Karl-Gösta Nygren and Petra Otterblad Olausson. "Cancer Risk in Children and Young Adults Conceived by In Vitro Fertilization." Pediatrics published online Jul 19, 2010;DOI: 10.1542/peds.2009-3225.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap